Completed NA INTERVENTIONAL 2-arm NCT01214317

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis (IMPAMS)

Study of Combinative Effect of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Patients With Aggressive Multiple Sclerosis

Sponsor: Isfahan University of Medical Sciences

Conditions Multiple Sclerosis

Interventions plasmapheresis

Updated 9 times since 2017 Last updated: Aug 27, 2020 Started: Jan 31, 2010 Primary completion: Jan 31, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Multiple Sclerosis, this trial is completed. The trial is conducted by Isfahan University of Medical Sciences and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Oct 2020 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Isfahan University of Medical Sciences

Data source: Isfahan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Isfahan, Iran